A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use

BACKGROUND: Glycopyrronium bromide has recently been approved as a once daily maintenance inhalation therapy for moderate to severe chronic obstructive pulmonary disease (COPD). Efficacy and safety trial data have found rare cases of significant QT prolongation. To our knowledge, we describe the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Michael H., Al-Majed, Nawaf S., Stubbins, Ryan, Pollmann, Dylan, Sandhu, Roopinder K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908703/
https://www.ncbi.nlm.nih.gov/pubmed/27301406
http://dx.doi.org/10.1186/s13104-016-2105-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908703/
https://www.ncbi.nlm.nih.gov/pubmed/27301406
http://dx.doi.org/10.1186/s13104-016-2105-4

Ejemplares similares